Shao et al. constructed a prognostic signature centered on ten ferroptosis-related genes (SP1, MYB, ALDH3A2, KEAP1, AIFM2, ITGB4, TGFBR1, MAP1LC3B, NOX4, and ZFP36) to evaluate the prognosis and immunotherapy in GC patients. This evidence concerns the gene ITGB4 and gastric cancer.